GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,600 GBX | +0.28% |
|
-1.05% | +10.30% |
| 24/06 | Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer | CI |
| 24/06 | European Equities Close Higher on Monday; EU Probes Apple for Breach of Digital Competition Law | MT |
Presenter SpeechNick Stone (Executives)Hello, everyone. Welcome to our next meet GSK managemen...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
GSK plc is a global biopharma company. The Companyâs segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Sector
Pharmaceuticals
Calendar
31/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.95
GBP
Average target price
20.36
GBP
Spread / Average Target
+27.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.30% | 82.43B | |
| +54.49% | 815B | |
| +44.25% | 654B | |
| -6.45% | 354B | |
| +21.62% | 337B | |
| +10.75% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +8.62% | 171B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GSK plc - Special Call
